Issue 32 | 2018
Get instant access to latest e-book

latest newsRead more...

24

Sep 2018

MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate

MEBIAS Discovery an emerging leader in the field of drug discovery targeting Gprotein coupled receptors has secured grant funding from the National Institute of Drug Abuse NIDA to progress a muopioid receptor candidate Preclinical data presented last year at the Academic Drug Discovery Consortium revealed…

24

Sep 2018

Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan for Frontline Hodgkin Lymphoma

Seattle Genetics Inc today announced that its collaborator Takeda Pharmaceutical Company Limited Takeda has received approval from the Japanese Ministry of Health Labour and Welfare for ADCETRIS brentuximab vedotin in combination with doxorubicin vinblastine and dacarbazine AVD as a frontline treatment option for CDpositive Hodgkin…

21

Sep 2018

Cardurion Pharmaceuticals Announces Initiation of Phase 1 Study of CRD-733, a PDE-9 Inhibitor in Development for the Treatment of Heart Failure

Cardurion Pharmaceuticals a biotechnology company focused on the development of novel nextgeneration therapeutics for the treatment of cardiovascular diseases today announced that the US Food and Drug Administration FDA has accepted its Investigational New Drug Application IND for CRD a Phosphodiesterase PDE inhibitor in development…

press releasesRead more...

24

Sep 2018

Takeda receives favorable opinion from the CHMP for ALUNBRIG ® (Brigatinib) for the treatment of ALK-positive non-small cell lung cancer in crizotinib-treated patients

Takeda Pharmaceutical Company Limited announced today that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has issued a favorable opinion Approval of ALUNBRIG…

22

Sep 2018

Teenager’s Lifesaving TickTracker App Recognized by Department of Health & Human Services

Denver Colo Sept GLOBE NEWSWIRE The new mobile application TickTracker created by Colorados yearold Olivia Goodreau will be joining a week tech development sprint lead by the Department of Health…

21

Sep 2018

Leading Online Supplement Marketplace HealthXP Signs Sahil Khan as Its Brand Ambassador in India

Business Wire IndiaHealthXP Indias fastest growing online health nutrition and sports supplement store is proud to announce its association with fitness icon Mr Sahil Khan in India Mr Khan who…

EventsRead more...

24-26

Sep 2018

Safety Labeling and Packaging

Exl Events
Hyatt Regency Morristown

24-26

Sep 2018

Cosmetics Compliance

IQPC Ltd
New York

TOP ARTICLES

  • 1

    Are you Ready for EU FMD?

    With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel explains how achieving compliance is about much more..
  • 3

    Cancer Stem Cell (CSC) Inhibitors

    Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..

Knowledge Bank

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia
    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot..

  • Articles

    Oral Formulation of Bio-pharmaceuticals

    Introduction There are several key factors making oral delivery systems the most attractive delivery route for pharmaceutical researchers and industry In addition to patients compliance oral delivery provides advantages such as a very large surface area for drug absorption about m elimination of hazardous wastes and applicability for solid drug formulations Furthermore the availability…

Editorial Section

  • Strategy

    Statin Drug Interactions and Related Adverse Reactions

    Statins are generally well tolerated with a low frequency of adverse events but since statins are prescribed on a longterm basis many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment and potentially interacting…

  • Research development

    Stem Cell and Gene Delivery

    These days gene and stem cell therapies have the potential to make the substantial impact on the treatment of several diseases However there are pros and cons of each strategy but the optimal selection of gene delivery vector or stem…

  • Clinical Trials

    Managing Clinical Trial Agreements

    Clinical Trial Agreements set out how a clinical trial will be run at the site and are an essential GCP document There are a number of key factors that determine whether a Clinical Trial Agreement is successful in achieving that…

  • Information Technology

    R&D DATA HUB

    Faster decision making and better trial oversight at all levels requires truly next generation data integration and analytics Source and format agnostic data aggregation aided by modern data lake architecture and advanced analytics deliver interactive…

TOP